vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and INDEPENDENT BANK CORP (INDB). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $212.5M, roughly 1.7× INDEPENDENT BANK CORP). INDEPENDENT BANK CORP runs the higher net margin — 35.5% vs -0.8%, a 36.2% gap on every dollar of revenue. On growth, INDEPENDENT BANK CORP posted the faster year-over-year revenue change (46.9% vs 9.4%). INDEPENDENT BANK CORP produced more free cash flow last quarter ($75.5M vs $36.1M). Over the past eight quarters, INDEPENDENT BANK CORP's revenue compounded faster (24.3% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Independent Bank is a bank headquartered in Grand Rapids, Michigan. The bank has 62 branches, all of which are in Michigan.
ASIX vs INDB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $212.5M |
| Net Profit | $-2.8M | $75.3M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | — |
| Net Margin | -0.8% | 35.5% |
| Revenue YoY | 9.4% | 46.9% |
| Net Profit YoY | -892.9% | 50.6% |
| EPS (diluted) | $-0.11 | $1.51 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $212.5M | ||
| Q3 25 | $374.5M | $203.3M | ||
| Q2 25 | $410.0M | $147.5M | ||
| Q1 25 | $377.8M | $145.5M | ||
| Q4 24 | $329.1M | $144.7M | ||
| Q3 24 | $398.2M | $141.7M | ||
| Q2 24 | $453.5M | $137.9M | ||
| Q1 24 | $336.8M | $137.4M |
| Q4 25 | $-2.8M | $75.3M | ||
| Q3 25 | $-2.6M | $34.3M | ||
| Q2 25 | $31.4M | $51.1M | ||
| Q1 25 | $23.3M | $44.4M | ||
| Q4 24 | $352.0K | $50.0M | ||
| Q3 24 | $22.3M | $42.9M | ||
| Q2 24 | $38.9M | $51.3M | ||
| Q1 24 | $-17.4M | $47.8M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | — | ||
| Q3 25 | -0.9% | 21.8% | ||
| Q2 25 | 7.7% | 44.6% | ||
| Q1 25 | 7.7% | 39.3% | ||
| Q4 24 | -3.9% | — | ||
| Q3 24 | 7.5% | 39.0% | ||
| Q2 24 | 11.5% | 48.1% | ||
| Q1 24 | -7.0% | 45.5% |
| Q4 25 | -0.8% | 35.5% | ||
| Q3 25 | -0.7% | 16.8% | ||
| Q2 25 | 7.7% | 34.6% | ||
| Q1 25 | 6.2% | 30.5% | ||
| Q4 24 | 0.1% | 34.6% | ||
| Q3 24 | 5.6% | 30.3% | ||
| Q2 24 | 8.6% | 37.2% | ||
| Q1 24 | -5.2% | 34.8% |
| Q4 25 | $-0.11 | $1.51 | ||
| Q3 25 | $-0.10 | $0.69 | ||
| Q2 25 | $1.15 | $1.20 | ||
| Q1 25 | $0.86 | $1.04 | ||
| Q4 24 | $0.02 | $1.18 | ||
| Q3 24 | $0.82 | $1.01 | ||
| Q2 24 | $1.43 | $1.21 | ||
| Q1 24 | $-0.65 | $1.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $3.6B |
| Total Assets | $1.7B | $24.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | — | ||
| Q3 25 | $23.7M | — | ||
| Q2 25 | $18.4M | — | ||
| Q1 25 | $8.3M | — | ||
| Q4 24 | $19.6M | — | ||
| Q3 24 | $17.3M | — | ||
| Q2 24 | $12.1M | — | ||
| Q1 24 | $20.6M | — |
| Q4 25 | $815.2M | $3.6B | ||
| Q3 25 | $818.2M | $3.5B | ||
| Q2 25 | $823.7M | $3.1B | ||
| Q1 25 | $794.4M | $3.0B | ||
| Q4 24 | $774.6M | $3.0B | ||
| Q3 24 | $766.4M | $3.0B | ||
| Q2 24 | $746.6M | $2.9B | ||
| Q1 24 | $713.2M | $2.9B |
| Q4 25 | $1.7B | $24.9B | ||
| Q3 25 | $1.7B | $25.0B | ||
| Q2 25 | $1.6B | $20.0B | ||
| Q1 25 | $1.6B | $19.9B | ||
| Q4 24 | $1.6B | $19.4B | ||
| Q3 24 | $1.5B | $19.4B | ||
| Q2 24 | $1.5B | $19.4B | ||
| Q1 24 | $1.5B | $19.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $78.9M |
| Free Cash FlowOCF − Capex | $36.1M | $75.5M |
| FCF MarginFCF / Revenue | 10.0% | 35.5% |
| Capex IntensityCapex / Revenue | 7.7% | 1.6% |
| Cash ConversionOCF / Net Profit | — | 1.05× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $239.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $78.9M | ||
| Q3 25 | $26.6M | $52.2M | ||
| Q2 25 | $21.1M | $106.7M | ||
| Q1 25 | $11.4M | $13.3M | ||
| Q4 24 | $64.2M | $42.9M | ||
| Q3 24 | $57.3M | $70.2M | ||
| Q2 24 | $50.2M | $65.6M | ||
| Q1 24 | $-36.2M | $51.1M |
| Q4 25 | $36.1M | $75.5M | ||
| Q3 25 | $66.0K | $49.7M | ||
| Q2 25 | $-7.2M | $102.5M | ||
| Q1 25 | $-22.6M | $11.3M | ||
| Q4 24 | $29.8M | $36.5M | ||
| Q3 24 | $26.8M | $64.4M | ||
| Q2 24 | $16.7M | $61.9M | ||
| Q1 24 | $-71.6M | $46.7M |
| Q4 25 | 10.0% | 35.5% | ||
| Q3 25 | 0.0% | 24.4% | ||
| Q2 25 | -1.7% | 69.5% | ||
| Q1 25 | -6.0% | 7.8% | ||
| Q4 24 | 9.1% | 25.2% | ||
| Q3 24 | 6.7% | 45.4% | ||
| Q2 24 | 3.7% | 44.9% | ||
| Q1 24 | -21.3% | 34.0% |
| Q4 25 | 7.7% | 1.6% | ||
| Q3 25 | 7.1% | 1.2% | ||
| Q2 25 | 6.9% | 2.9% | ||
| Q1 25 | 9.0% | 1.4% | ||
| Q4 24 | 10.4% | 4.4% | ||
| Q3 24 | 7.7% | 4.1% | ||
| Q2 24 | 7.4% | 2.7% | ||
| Q1 24 | 10.5% | 3.2% |
| Q4 25 | — | 1.05× | ||
| Q3 25 | — | 1.52× | ||
| Q2 25 | 0.67× | 2.09× | ||
| Q1 25 | 0.49× | 0.30× | ||
| Q4 24 | 182.29× | 0.86× | ||
| Q3 24 | 2.57× | 1.64× | ||
| Q2 24 | 1.29× | 1.28× | ||
| Q1 24 | — | 1.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
INDB
Segment breakdown not available.
